Healthcare provider profile · identity verified

Alexandra Kovaleva, M.D.

Internal Medicine · TINTON FALLS, NJ · NPI 1487063855

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	483	106
Atorvastatin Calcium	Atorvastatin Calcium	376	106
Amlodipine Besylate	Amlodipine Besylate	301	84
Furosemide	Furosemide	282	60
Pantoprazole Sodium	Pantoprazole Sodium	267	71
Eliquis	Apixaban	209	35
Metoprolol Succinate	Metoprolol Succinate	204	57
Gabapentin	Gabapentin	169	47
Rosuvastatin Calcium	Rosuvastatin Calcium	168	35
Sertraline Hcl	Sertraline Hcl	165	30
Losartan Potassium	Losartan Potassium	154	42
Donepezil Hcl	Donepezil Hcl	152	36
Escitalopram Oxalate	Escitalopram Oxalate	136	34
Potassium Chloride	Potassium Chloride	129	31
Mirtazapine	Mirtazapine	128	37
Metoprolol Tartrate	Metoprolol Tartrate	112	26
Tamsulosin Hcl	Tamsulosin Hcl	110	32
Famotidine	Famotidine	108	32
Alprazolam	Alprazolam	102	33
Simvastatin	Simvastatin	95	21
Tramadol Hcl	Tramadol Hcl	92	42
Omeprazole	Omeprazole	84	19
Carvedilol	Carvedilol	79	20
Metformin Hcl	Metformin Hcl	79	19
Pravastatin Sodium	Pravastatin Sodium	78	16
Ezetimibe	Ezetimibe	73	18
Warfarin Sodium	Warfarin Sodium	73	suppressed
Hydralazine Hcl	Hydralazine Hcl	68	19
Lisinopril	Lisinopril	61	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	17
Hydrochlorothiazide	Hydrochlorothiazide	59	16
Valsartan	Valsartan	57	15
Levetiracetam	Levetiracetam	52	suppressed
Finasteride	Finasteride	51	13
Buspirone Hcl	Buspirone Hcl	50	suppressed
Enalapril Maleate	Enalapril Maleate	46	suppressed
Jardiance	Empagliflozin	46	suppressed
Pregabalin	Pregabalin	46	suppressed
Alendronate Sodium	Alendronate Sodium	44	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	44	suppressed
Prednisone	Prednisone	43	30
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	38
Carbidopa-Levodopa	Carbidopa/Levodopa	38	suppressed
Trazodone Hcl	Trazodone Hcl	38	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	24
Xarelto	Rivaroxaban	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Meloxicam	Meloxicam	35	17
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	34	26
Spironolactone	Spironolactone	34	suppressed
Repaglinide	Repaglinide	33	suppressed
Allopurinol	Allopurinol	32	11
Triamcinolone Acetonide	Triamcinolone Acetonide	32	12
Cefuroxime	Cefuroxime Axetil	31	25
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	11
Memantine Hcl	Memantine Hcl	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Folic Acid	Folic Acid	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Nifedipine Er	Nifedipine	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	26	suppressed
Atenolol	Atenolol	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	13
Latanoprost	Latanoprost	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	19
Lamotrigine	Lamotrigine	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Midodrine Hcl	Midodrine Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Ranolazine Er	Ranolazine	23	suppressed
Cefdinir	Cefdinir	22	20
Divalproex Sodium	Divalproex Sodium	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	21	suppressed
Nystatin	Nystatin	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	14
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Digoxin	Digoxin	18	suppressed
Klor-Con 10	Potassium Chloride	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	12
Azithromycin	Azithromycin	17	17
Brimonidine Tartrate	Brimonidine Tartrate	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	11
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Clonazepam	Clonazepam	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	14	14
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Multaq	Dronedarone Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clobetasol Emollient	Clobetasol Propionate/Emoll	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Nystop	Nystatin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Tradjenta	Linagliptin	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Diazepam	Diazepam	11	suppressed
Dofetilide	Dofetilide	11	suppressed
Galantamine Er	Galantamine Hbr	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error